Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients

被引:84
作者
Gerna, G [1 ]
Vitulo, P
Rovida, F
Lilleri, D
Pellegrini, C
Oggionni, T
Campanini, G
Baldanti, F
Revello, MG
机构
[1] Univ Pavia, Policlin San Matteo, IRCCS, Serv Virol, I-27100 Pavia, Italy
[2] Univ Pavia, Policlin San Matteo, IRCCS, Div Cardiochirurg, I-27100 Pavia, Italy
[3] Univ Pavia, Ist Malattie Apparato Resp, I-27100 Pavia, Italy
关键词
human metapneumovirus; human cytomegalovirus; lung transplant recipients; respiratory tract viral infections; nasopharyngeal aspirates; bronchoalveolar lavage; reverse transcription-polymerase chain reaction (RT-PCR);
D O I
10.1002/jmv.20555
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Viral respiratory tract infections in lung transplant recipients may be severe. During three consecutive winter-spring seasons, 49 symptomatic lung transplant recipients with suspected respiratory viral infection, and 26 asymptomatic patients were investigated for presence of respiratory viruses either in 56 nasopharyngeal aspirate or 72 bronchoalveolar lavage samples taken at different times after transplantation. On the whole, 1 asymptomatic (3.4%) and 28 symptomatic (57.1%) patients were positive for human metapneumovirus (hMPV, 4 patients), influenza virus A (3 patients), and B (2 patients), respiratory syncytial virus (2 patients), human coronavirus (2 patients), human parainfluenza virus (2 patients), rhinovirus (5 patients), while 4 patients were coinfected by 2 respiratory viruses, and 5 were infected sequentially by 2 or more respiratory viruses. In bronchoalveolar lavage samples, hMPV predominated by far over the other viruses, being responsible for 60% of positive specimens, whereas other viruses were present in nasopharyngeal aspirates at a comparable rate. RT-PCR (detecting 43 positive samples/128 examined) was largely superior to monoclonal antibodies (detecting 17 positive samples only). In addition, HCMV was detected in association with a respiratory virus in 4/18 HCMV-positive patients, and was found at a high concentration (>10(5) DNA copies/ml) in 3/16 (18.7%) patients with HCMV-positive bronchoalveolar lavage samples and pneumonia. Coinfections and sequential infections by HCMV and respiratory viruses were significantly more frequent in patients with acute rejection and steroid treatment. In conclusion: (i) about 50% of respiratory tract infections of lung transplant recipients were associated with one or more respiratory viruses; (ii) hMPV largely predominates in bronchoalveolar lavage of symptomatic lung transplant recipients, thus suggesting a causative role in lower respiratory tract infections; (iii) RTPCR appears to be the method of choice for detection of respiratory viruses in lung transplant recipients, (iv) a high HCMV load in bronchoalveolar lavage is a risk factor for viral pneumonia, suggesting some measure of intervention for the control of viral infection.
引用
收藏
页码:408 / 416
页数:9
相关论文
共 39 条
  • [1] QUANTITATIVE-ANALYSIS OF CYTOMEGALOVIRUS VIREMIA IN LUNG-TRANSPLANT RECIPIENTS
    BAILEY, TC
    BULLER, RS
    ETTINGER, NA
    TRULOCK, EP
    GAUDREAULTKEENER, M
    LANGLOIS, TM
    FORNOFF, JER
    COOPER, JD
    STORCH, GA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) : 1006 - 1010
  • [2] Respiratory viruses and chronic rejection in lung transplant recipients
    Billings, JL
    Hertz, MI
    Savik, K
    Wendt, CH
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (05) : 559 - 566
  • [3] Adenovirus infection in the lung results in graft failure after lung transplantation
    Bridges, ND
    Spray, TL
    Collins, MH
    Bowles, NE
    Towbin, JA
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (04) : 617 - 623
  • [4] Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay
    Coiras, MT
    Pérez-Breña, P
    García, ML
    Casas, I
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2003, 69 (01) : 132 - 144
  • [5] Influenza pneumonia in lung transplant recipients - Clinical features and association with bronchiolitis obliterans syndrome
    Garantziotis, S
    Howell, DN
    McAdams, HP
    Davis, RD
    Henshaw, NG
    Palmer, SM
    [J]. CHEST, 2001, 119 (04) : 1277 - 1280
  • [6] Lower respiratory viral illnesses - Improved diagnosis by molecular methods and clinical impact
    Garbino, J
    Gerbase, MW
    Wunderli, W
    Deffernez, C
    Thomas, Y
    Rochat, T
    Ninet, B
    Schrenzel, J
    Yerly, S
    Perrin, L
    Soccal, PM
    Nicod, L
    Kaiser, L
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (11) : 1197 - 1203
  • [7] Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells
    Gerna, G
    Percivalle, E
    Lilleri, D
    Lozza, L
    Fornara, C
    Hahn, G
    Baldanti, F
    Revello, MG
    [J]. JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 275 - 284
  • [8] Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients:: A prospective, randomized, controlled, open-label trial.
    Gerna, G
    Baldanti, F
    Lilleri, D
    Parea, M
    Torsellini, M
    Castiglioni, B
    Vitulo, P
    Pellegrini, C
    Viganò, M
    Grossi, P
    Revello, MG
    [J]. TRANSPLANTATION, 2003, 75 (07) : 1012 - 1019
  • [9] COMPARISON OF DIFFERENT IMMUNOSTAINING TECHNIQUES AND MONOCLONAL-ANTIBODIES TO THE LOWER MATRIX PHOSPHOPROTEIN (PP65) FOR OPTIMAL QUANTITATION OF HUMAN CYTOMEGALOVIRUS ANTIGENEMIA
    GERNA, G
    REVELLO, MG
    PERCIVALLE, E
    MORINI, F
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (05) : 1232 - 1237
  • [10] EFFECT OF FOSCARNET INDUCTION TREATMENT ON QUANTITATION OF HUMAN CYTOMEGALOVIRUS (HCMV) DNA IN PERIPHERAL-BLOOD POLYMORPHONUCLEAR LEUKOCYTES AND AQUEOUS-HUMOR OF AIDS PATIENTS WITH HCMV RETINITIS
    GERNA, G
    BALDANTI, F
    SARASINI, A
    FURIONE, M
    PERCIVALLE, E
    REVELLO, MG
    ZIPETO, D
    ZELLA, D
    CAROSI, GP
    CASTELLI, F
    MINOLI, R
    GROSSI, P
    MORONI, M
    DARMINIO, A
    COPPIN, P
    ORANI, A
    BOLIS, D
    LAZZARIN, A
    GIANOTTI, N
    CARNEVALE, G
    PAN, A
    SUTER, F
    PELLEGATA, G
    FIORI, GP
    ZEROLI, C
    CHIODO, F
    CORONADO, O
    FIACCADORI, F
    MAGNANI, G
    ALBERICI, F
    VIALE, P
    GIANNELLI, F
    GAGGESE, L
    CADROBBI, P
    SCAGGIANTE, R
    CADEO, GP
    COSTA, P
    GAFA, S
    GIUDICI, MG
    AMBROSOLI, L
    ANTONIAZZI, E
    TRIMARCHI, F
    BERTONI, G
    BLINI, M
    DEANGELIS, S
    LANZA, E
    VERGANI, A
    CARRAI, M
    CAZZOLA, A
    CERRI, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (01) : 38 - 44